GEODE CAPITAL MANAGEMENT, LLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in LENZ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,799,851

-$2,577,349 QoQ

Shares Held

524,574

+13.8% QoQ

Ownership

1.67%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,556,460,669 across 523 Biotechnology names. LENZ ranks #215 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,799,851	524,574	+13.8%	Shares	Defined	2026-05-15
2025-12-31	$7,377,200	461,075	+1.4%	Shares	Defined	2026-02-09
2025-09-30	$21,189,055	454,896	+9.3%	Shares	Defined	2025-11-12
2025-06-30	$12,196,534	416,122	+15.5%	Shares	Defined	2025-08-08
2025-03-31	$9,265,677	360,392	+7.9%	Shares	Defined	2025-05-13
2024-12-31	$9,643,329	334,026	-1.2%	Shares	Defined	2025-02-12
2024-09-30	$8,024,689	338,024	-6.1%	Shares	Defined	2024-11-12
2024-06-30	$6,226,474	360,120	+308.2%	Shares	Defined	2024-08-09
2024-03-31	$1,969,907	88,218	—	Shares	Defined	2024-05-13
No filing history on record for this holder in this stock.